FATN vs. ERNA

Last updated Aug 1, 2026

FATN (FatPipe, Inc) and ERNA (Eterna Therapeutics Inc) are both stocks. FATN operates in Software - Infrastructure (Technology), while ERNA operates in Biotechnology (Healthcare). Over the past year, FATN returned 3.58% vs -91.59% for ERNA. Their 0.04 correlation means their historical movements had little consistent relationship.

Performance

FATN vs. ERNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FatPipe, Inc (FATN) and Eterna Therapeutics Inc (ERNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FATN achieves a 200.99% return, which is significantly higher than ERNA's -89.07% return.

FATN

• 1D: 18.75%
• 1M: 1.67%
• 6M: 241.57%
• YTD: 200.99%
• 1Y: 3.58%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: -4.97%

ERNA

• 1D: -5.48%
• 1M: -47.69%
• 6M: -89.25%
• YTD: -89.07%
• 1Y: -91.59%
• 3Y*: -85.19%
• 5Y*: -86.94%
• 10Y*: -64.30%
• ALL TIME*: -33.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ERNA Eterna Therapeutics Inc	$350.09K	$8.77M	$15.38M
FATN FatPipe, Inc	$555.65K	$467.45K	$1.86M

FATN vs. ERNA - Yearly Performance Comparison

	2026 (YTD)	2025
FATN FatPipe, Inc	200.99%	-68.92%
ERNA Eterna Therapeutics Inc	-89.07%	-57.08%

Correlation

The correlation between FATN and ERNA is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.03
Correlation (All Time) Calculated using the full available price history since Apr 8, 2025	0.04

Fundamentals

Market Cap FATN : $85.27M ERNA : $1.03M
EPS FATN : $0.39 ERNA : -$23.80
PB Ratio FATN : 3.23 ERNA : 0.38
Total Revenue (TTM) FATN : $20.30M ERNA : $0.00
Gross Profit (TTM) FATN : $17.68M ERNA : -$69.00K
EBITDA (TTM) FATN : $4.11M ERNA : -$11.25M

Return for Risk

FATN vs. ERNA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FATN

FATN Risk / Return Rank: 50
FATN Sharpe Ratio Rank: 42
FATN Sortino Ratio Rank: 63
FATN Omega Ratio Rank: 60
FATN Calmar Ratio Rank: 41
FATN Martin Ratio Rank: 42

ERNA

ERNA Risk / Return Rank: 8
ERNA Sharpe Ratio Rank: 17
ERNA Sortino Ratio Rank: 6
ERNA Omega Ratio Rank: 8
ERNA Calmar Ratio Rank: 2
ERNA Martin Ratio Rank: 6

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FATN vs. ERNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for FatPipe, Inc (FATN) and Eterna Therapeutics Inc (ERNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FATN	ERNA	Difference
Sharpe ratio: Return per unit of total volatility	-0.05	-0.60	+0.55
Sortino ratio: Return per unit of downside risk	1.20	-1.53	+2.73
Omega ratio: Gain probability vs. loss probability	1.14	0.82	+0.32
Calmar ratio: Return relative to maximum drawdown	-0.09	-0.99	+0.91
Martin ratio: Return relative to average drawdown	-0.12	-1.47	+1.35

FATN vs. ERNA - Sharpe Ratio Comparison

The current FATN Sharpe Ratio is -0.05, which is higher than the ERNA Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of FATN and ERNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FATN vs. ERNA - Drawdown Comparison

The maximum FATN drawdown since its inception was -88.85%, smaller than the maximum ERNA drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for FATN and ERNA.

Drawdown Indicators

	FATN	ERNA	Difference
Max Drawdown Largest peak-to-trough decline	-88.85%	-100.00%	+11.15%
Max Drawdown (1Y) Largest decline over 1 year	-83.69%	-93.02%	+9.33%
Max Drawdown (3Y) Largest decline over 3 years	—	-99.70%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-100.00%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	-53.23%	-100.00%	+46.77%
Average Drawdown Average peak-to-trough decline	-60.81%	-86.20%	+25.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	58.83%	62.71%	-3.88%

Volatility

FATN vs. ERNA - Volatility Comparison

The current volatility for FatPipe, Inc (FATN) is 31.02%, while Eterna Therapeutics Inc (ERNA) has a volatility of 35.09%. This indicates that FATN experiences smaller price fluctuations and is considered to be less risky than ERNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FATN	ERNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.02%	35.09%	-4.07%
Volatility (6M) Calculated over the trailing 6-month period	115.72%	132.84%	-17.12%
Volatility (1Y) Calculated over the trailing 1-year period	150.70%	154.51%	-3.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	178.32%	114.04%	+64.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	178.32%	149.29%	+29.03%

Dividends

FATN vs. ERNA - Dividend Comparison

Neither FATN nor ERNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both FATN and ERNA in my portfolio?

FATN and ERNA have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FATN or ERNA?

ERNA has higher volatility (35.09%) compared to FATN (31.02%). In terms of maximum drawdown, FATN dropped -88.85% vs ERNA's -100.00%.

Which has better risk-adjusted returns?

FATN currently has the higher Sharpe Ratio (-0.05 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.